
SME IPO
Amtech Esters IPO
Prices in INR · Times in IST
GMP updated: 17 Sep 2026, 08:24 AM IST
- Price band
- ₹71 – ₹75
- Application estimate
- ₹2,40,0002 lot(s) · 1600 sh
- GMP · unofficial
- ₹16 (+21.33%)
- Est. listing price
- ₹91Issue price + GMP
- Issue size
- ₹17.88 Cr
- Total subscription
- 25.78×
GMP trend & intraday history
Hover or tap on the chart to inspect a reading. Dates use calendar spacing; large gaps are not connected.
- High in this view
- ₹16 (₹51,200)
- Low in this view
- ₹5 (₹16,000)
- Reference issue price
- ₹75
- Readings in this view
- 14
Issue at a glance
IPO timetable & schedule
Subscription by investor category
Source updated: 17 Nov 2026, 04:21 PM IST
Overall Demand: 25.78×Mainboard figures are consolidated. NSE and BSE demand is not added together. Rupee demand is calculated from bid shares and the cap price; it is not an exchange-published amount. Application source: boa.
QIB funding cost illustration
Arithmetic for a fully funded institutional bid over 7 days; not a recommendation or a retail return estimate.
- Days
- 7
- Interest Rate
- Not published
- Cost Per Share
- 1130.25
Day-wise subscription history
One snapshot near each bidding day’s close. This is not a continuous intraday series.
Plan your application
SME individual applications use 2 lots and must exceed ₹2 lakh under the NSE process effective July 2025.
The source application tiers need verification: a one-lot retail tier does not match the newer SME process. Use the rule-based estimate above and confirm the offer document.
One lot: ₹1,20,000 · Allocation is not guaranteed. Broker cut-off times may differ.
Source-published application tiers
Before you place an IPO application
- Read the issue. Check the offer document, business risks, price band and your application category.
- Apply through your broker or bank. Use your existing broker’s IPO section or your bank’s ASBA facility. This page does not submit a bid.
- Check the payment step. If using UPI, confirm the mandate in your UPI app and check that the funds are blocked. A saved bid alone is not confirmation.
- Track what happens next. Keep your application number. Use the registrar’s official page for allotment and the published timeline for refunds, demat credit and listing.
GMP return scenario
What could this amount look like?
GMP-based scenario · Not a forecast
Assumes all requested shares are allotted and listing equals issue price + GMP. Actual allotment, listing price, fees and taxes can change the result.
Your IPO progress
Keep your own record of this IPO. Statuses are entered by you, not verified with a broker or registrar. Saved on this browser for your signed-in account; not synced across devices.
IPO reservation & shares offered
Shares offered by category
Category-wise allocation percentages follow SEBI ICDR norms as stated in the offer document.
Promoter holding & ownership
Ajit Singh Bawa, Gurpreet Kaur Bawa and Meenakshi Sharma
Anchor investors & allocations
- Anchor entities
- 0
- Total allocation (₹ crore)
- 0
- Mutual fund allottees
- 0
- Official allocation document
- Anchor document: not published
Investor allocations
No data has been published for this section yet.
By fund house
No data has been published for this section yet.
Financials & valuation
Figures in Rs. Crore · Changes compare matching annual period-end dates only.
- Profit After Tax
- 4.22Latest: 31 Mar 2026+13.44% YoY · Prior 3.72
- EBITDA
- 7.49Latest: 31 Mar 2026+15.23% YoY · Prior 6.5
- Total Borrowing
- 3.41Latest: 31 Mar 2026-14.54% YoY · Prior 3.99
Rs. Crore
Key valuation & financial KPIs
- EPS (₹)
- 4.78
- RoCE
- 35.10%
- RoNW
- 27.58%
- PAT Margin
- 10.09%
What does the company do?
Amtech Esters Limited was started in May 2002 and became a public limited company in December 2023. It is a business to business chemical manufacturer, which means it sells to other companies rather than to the public. Its main product is Unsaturated Polyester Resin, usually called UPR. This is the resin used to make fibre reinforced plastic, or FRP, products. Alongside the resin it makes and supplies related items such as fibreglass, hardeners, silicones and other products used in the same work. By offering these together it lets a customer buy everything needed for a job from one place, from the base resin and reinforcement through to curing and finishing materials. The company also owns Croda Pigments Private Limited as a wholly owned subsidiary. That company makes pigments, which are the colouring and additive materials used in paints, varnishes, dyes, glues and gums, and it widens the group's overall range. Amtech Esters has its own research and development and quality control departments and holds ISO 9001:2015 certification. Its plant is at Bahadurgarh in Jhajjar district, Haryana. As on 31 March 2026 it had 60 employees.
More about the business
Amtech Esters Limited manufactures Unsaturated Polyester Resins and trades complementary products such as fibreglass, hardeners and silicones used across the resin and FRP value chain. It runs an ISO 9001:2015 certified plant at Bahadurgarh in Haryana and makes pigments through its subsidiary Croda Pigments.
Where will the money go?
Strengths & risks
Business strengths
- Profit has grown every year, from Rs 2.84 crore in FY2024 to Rs 3.72 crore in FY2025 and Rs 4.22 crore in FY2026.
- Sales have grown from Rs 27.24 crore in FY2024 to Rs 36.97 crore in FY2025 and Rs 40.75 crore in FY2026.
- EBITDA improved sharply, from Rs 1.65 crore in FY2024 to Rs 6.50 crore in FY2025 and Rs 7.49 crore in FY2026.
- Return ratios are strong, with RoCE of 35.10% and RoNW of 27.58%, and a PAT margin of 10.09%.
- The company carries little debt. Borrowing was Rs 3.41 crore against a net worth of Rs 19.58 crore, and it has come down every year.
- Offering the resin along with fibreglass, hardeners and silicones gives customers a single source for a whole job, which helps hold on to them.
- The subsidiary Croda Pigments adds pigments to the range, which sells into paints, varnishes, dyes and glues.
- It has a long record of over 20 years, holds ISO 9001:2015 certification and has its own R&D and quality control departments.
Risks to understand
- The P/E is not stated in the data available to us, so the issue cannot be compared with peers on earnings from here.
- Growth has slowed. Total income rose only 10% in FY2026 against 36% the year before.
- This is a very small company, with a net worth of Rs 19.58 crore and 60 employees.
- Unsaturated Polyester Resin is made from petrochemical feedstock, so raw material cost moves with crude oil and cannot always be passed on.
- A part of the business is trading rather than manufacturing, which normally earns a lower margin.
- Rs 8.81 crore of the issue money goes into the subsidiary Croda Pigments as debt rather than into the parent company's own capacity.
- A further part is kept for unidentified acquisitions along with general corporate purposes, so investors do not know where that money will go.
- The whole business runs from one plant at Bahadurgarh in Haryana, so there is single location risk.
- Promoter holding is already moderate at 62.35% and falls to 45.52% after the issue, leaving the promoters below a half share.
- This is an SME issue. One lot is 1,600 shares, which is Rs 1.20 lakh at the upper band of Rs 75, and SME shares usually trade in low volume after listing.
Source-provided company information. Read the RHP for the complete risk factors; these points are not a recommendation.
Listing performance
Actual listing figures appear after listing. Current gain is source-adjusted for corporate actions. CMP is a source snapshot, not a streaming quote.
Official documents, registrar & contacts
Offer documents
Maashitla Securities Private Limited
Phone: 011-45121795
Email: ipo@maashitla.com
Allotment date: 15 Sep 2026
Lead manager details not yet published.
Flat No. 102, Plot No. A – 3, Magnum House 1, Commercial Complex, Karam Pura, West Delhi, New Delhi, West Delhi, New Delhi, 110015
Phone: 011-49044111
Email: info@amtechesters.com
Continue your IPO research
Explore more IPO companies
Related by issue type, with active issues first. These are research links, not investment recommendations.